Drug-suicide link complex, data elusive

Is it possible to draw a straight line between patient suicide and prescription drugs? It's a touchy subject. Within the last few weeks, the FDA alerted the public that epilepsy drugs appear to boost the remote risk of suicide (or at least suicidal thoughts), that Pfizer's stop-smoking drug Chantix may do the same, and that it's requiring more suicide-related data in drug trials. Is suicide the scary drug risk du jour? Or is the explosion activity long overdue?

The New York Times examines the question today and basically concludes that clarity will be elusive. Unless, that is, lawmakers mandate massive databases of patient-and-drug info designed to sift out rare side effects.

- check out the NYT's release

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.